首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1621926

脫髮市場機會、成長動力、行業趨勢分析和預測 2024 - 2032

Alopecia Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月01日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球脫髮市場估值為87 億美元，預計2024 年至2032 年間將以8.1% 的複合年成長率成長。的。遺傳傾向、荷爾蒙變化、自體免疫疾病和環境壓力等多種因素導致脫髮病例數量不斷增加。此外，不良飲食和壓力等生活方式因素會進一步加劇掉髮，促使更多人尋求有效的治療方法。全球有數百萬人受到脫髮的影響，對藥物治療和先進頭髮修復技術的需求正在增加。

隨著越來越多的人探索治療脫髮的治療方案，不斷成長的患者群體推動了市場的成長。就疾病類型而言，市場分為雄性禿、斑禿和其他形式的脫髮。雄性禿（俗稱斑禿）在 2023 年所佔佔有率最大，產生約 48 億美元的收入。雄性禿影響很大比例的男性，尤其是隨著年齡的成長，它仍然是市場治療需求的主要驅動力。

按治療類型分類，藥品在 2023 年佔據領先地位，佔總市場佔有率的 48.8%。藥物治療（無論是局部治療還是口服治療）的有效性得到了廣泛認可，由於其非侵入性且經證實能夠刺激頭髮再生，因此通常是治療脫髮的首選。它們的可及性和易用性使其成為患者的首選。北美脫髮市場在2023 年創造了32 億美元的收入，預計到2032 年將以7.7% 的複合年成長率成長。治療的需求。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	87 億美元
預測值	173 億美元
複合年成長率	8.1%

產業生態系統分析
產業影響力
- 成長動力
  - 脫髮症盛行率增加
  - 治療方案的技術進步
  - 人們對脫髮治療方案的認知不斷提高
  - 對藥物和治療的需求不斷成長
- 產業陷阱與挑戰
  - 治療取得方面的監管障礙
成長潛力分析
監管環境
技術景觀
消費者偏好
波特的分析
PESTEL分析
未來市場趨勢
差距分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按疾病類型，2021 - 2032

主要趨勢
雄性禿
斑禿
其他疾病類型

第 6 章：市場估計與預測：按治療類型，2021 - 2032 年

主要趨勢
製藥
- 專題
- 口服
裝置
- 雷射帽
- 雷射梳
- 雷射頭盔
其他治療

第 7 章：市場估計與預測：按性別分類，2021 - 2032 年

主要趨勢
男性
女性

第 8 章：市場估計與預測：按銷售管道分類，2021 - 2032 年

主要趨勢
處方
場外交易

第 9 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
皮膚科診所
家庭護理設置
其他最終用戶

第 10 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

Apira Science, Inc. (iGROW Laser)
Aurobindo Pharma
Bosley - Hair Restoration & Transplant
Cipla
Curallux, LLC
Dr. Reddy's Laboratories Ltd.
Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
Johnson & Johnson Services, Inc.
Lexington International., LLC
Merck KGaA
Pfizer Inc.
REVIAN, Inc.
Smart Graft
Sun Pharmaceuticals Industries Ltd.
Theradome Inc.

簡介目錄

Product Code: 11643

The Global Alopecia Market was valued at USD 8.7 billion in 2023 and is anticipated to grow at a CAGR of 8.1% between 2024 and 2032. The market expansion is primarily driven by the rising prevalence of alopecia and increased awareness of available treatment options. Various factors, such as genetic predispositions, hormonal changes, autoimmune conditions, and environmental stressors, contribute to the growing number of alopecia cases. Additionally, lifestyle factors like poor diet and stress further aggravate hair loss, pushing more individuals to seek effective treatments. With millions affected by alopecia globally, the demand for both pharmaceutical treatments and advanced hair restoration technologies is on the rise.

This growing patient base propels market growth, as more people explore treatment options to combat hair loss. In terms of disease type, the market is segmented into androgenetic alopecia, alopecia areata, and other forms of hair loss. Androgenetic alopecia, commonly known as pattern baldness, accounted for the largest share in 2023, generating around USD 4.8 billion in revenue. Affecting a significant percentage of men, particularly as they age, androgenetic alopecia remains a dominant driver of market demand for treatments.

When categorized by treatment type, pharmaceuticals took the lead in 2023, claiming 48.8% of the total market share. Widely recognized for their effectiveness, pharmaceutical treatments-both topical and oral-are often the first choice for treating alopecia due to their non-invasive nature and proven ability to stimulate hair regrowth. Their accessibility and ease of use make them the most preferred option among patients. North America alopecia market, which generated USD 3.2 billion in revenue in 2023, is expected to grow at a 7.7% CAGR through 2032. The high incidence of alopecia in the region, particularly androgenetic alopecia, drives the demand for innovative and effective treatments.With a large portion of the population affected by hair loss, North America continues to be a key market contributing to overall industry growth.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$8.7 Billion
Forecast Value	$17.3 Billion
CAGR	8.1%

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of alopecia
  - 3.2.1.2 Technological advancements in treatment regimes
  - 3.2.1.3 Growing awareness about alopecia treatment options
  - 3.2.1.4 Rising demand for drugs and treatments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory barriers in treatment access
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Consumer preference
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Androgenetic alopecia
5.3 Alopecia areata
5.4 Other disease types

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Pharmaceutical
- 6.2.1 Topical
- 6.2.2 Oral
6.3 Device
- 6.3.1 Laser cap
- 6.3.2 Laser comb
- 6.3.3 Laser helmet
6.4 Other treatments

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Male
7.3 Female

Chapter 8 Market Estimates and Forecast, By Sales Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Prescription
8.3 OTC

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Dermatology clinics
9.3 Homecare settings
9.4 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa